Stock Research: Dr. Reddy's

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Dr. Reddy's

BSE:500124 INE089A01023
26
  • Value
    70
  • Growth
    11
  • Safety
    Safety
    52
  • Combined
    29
  • Sentiment
    33
  • 360° View
    360° View
    26
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. It operates in the pharmaceutical industry, specializing in APIs, generics, branded generics, biosimilars, and OTC pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. In the last fiscal year, the company had a market cap of $12,191 million, profits of $2,558 million, and revenue of $3,820 million, with 26944 employees.

more
Index
Good Governace Growth Markets
Independent Boards Growth Markets
Low Waste
Recycling
CNX Nifty 50
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
70 65 63 61
Growth
11 13 31 47
Safety
Safety
52 51 59 47
Sentiment
33 43 84 50
360° View
360° View
26 25 76 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
18 21 38 83
Opinions Change
40 10 39 50
Pro Holdings
n/a 54 99 8
Market Pulse
74 88 77 57
Sentiment
33 43 84 50
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
70 65 63 61
Growth
11 13 31 47
Safety Safety
52 51 59 47
Combined
29 21 53 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
70 75 82 63
Price vs. Earnings (P/E)
64 56 62 61
Price vs. Book (P/B)
66 57 62 58
Dividend Yield
40 42 37 42
Value
70 65 63 61
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
10 48 17 46
Profit Growth
14 25 51 86
Capital Growth
24 1 46 42
Stock Returns
65 43 67 21
Growth
11 13 31 47
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 56 60 44
Refinancing
71 72 74 66
Liquidity
42 46 52 47
Safety Safety
52 51 59 47

Similar Stocks

Discover high‑ranked alternatives to Dr. Reddy's and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock is a good value with safe financing, but has low growth and negative sentiment. It is a good option for a cautious value investor looking for stability but who can tolerate low momentum and skeptical professional opinion.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: